SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-012992
Filing Date
2022-03-31
Accepted
2022-03-31 16:06:21
Documents
14
Period of Report
2022-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K celu-8k_20220331.htm   iXBRL 8-K 42929
2 EX-99.1 celu-ex991_6.htm EX-99.1 285670
  Complete submission text file 0001564590-22-012992.txt   511200

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA celu-20220331.xsd EX-101.SCH 5933
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celu-20220331_def.xml EX-101.DEF 13985
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE celu-20220331_lab.xml EX-101.LAB 23900
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celu-20220331_pre.xml EX-101.PRE 14744
8 EXTRACTED XBRL INSTANCE DOCUMENT celu-8k_20220331_htm.xml XML 5572
Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 22792436
SIC: 2834 Pharmaceutical Preparations